Incannex Healthcare
IXHL
4 hedge funds and large institutions have $139K invested in Incannex Healthcare in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
17% less capital invested
Capital invested by funds: $167K → $139K (-$27.9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$78.3K |
| 2 |
Jane Street
New York
|
+$27K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$69K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.37K |
IXHL Hedge Fund Activity: Q4 2022 in Review
4 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Incannex Healthcare (IXHL) for Q4 2022, worth a combined $139K — down 17% from $167K a quarter earlier.
Fund positioning in IXHL was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Old Mission Capital, opening a new position worth an estimated $78.3K. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $69K sold.
- 4 institutional investors held Incannex Healthcare (IXHL) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $139K of Incannex Healthcare stock for Q4 2022, down 17% quarter-over-quarter.
- 1 fund opened new Incannex Healthcare positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest Incannex Healthcare buyer in Q4 2022 was Old Mission Capital, an estimated $78.3K added.
- The largest Incannex Healthcare seller in Q4 2022 was FNY Investment Advisers, an estimated $69K sold.
Based on aggregated 13F filings for Q4 2022.